Karen Lewis, Chief People Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 2,133 shares at $65.53 ($139K) on 2024-01-30, disclosed to the SEC on 2024-01-31.
Scheduled sale ($139k) by Chief People Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.14 | 367 | $24K | 16.9% |
| 2 | $65.53 | 883 | $58K | 41.5% |
| 3 | $65.53 | 883 | $58K | 41.5% |
| Total | $65.29 avg | 2,133 | $139K | 100% |
| Filing → |
| APLS | SELL | 2025-01-21 | $37K | — | Filing → |
| APLS | SELL | 2025-01-14 | $46K | — | Filing → |
| APLS | SELL | 2024-01-24 | $546K | — | Filing → |